The breadth of the neutralizing antibody response to original SARS‐CoV‐2 infection is linked to the presence of Long COVID symptoms
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.29216 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Amanda M Buck und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Post-Acute COVID-19 Syndrome, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIH HHS.
Abstract (Originalsprache)
The associations between longitudinal dynamics and the breadth of SARS‐CoV‐2 neutralizing antibody (nAb) response with various Long COVID phenotypes before vaccination are not known. The capacity of antibodies to cross‐neutralize a variety of viral variants may be associated with ongoing pathology and persistent symptoms. We measured longitudinal neutralizing and cross‐neutralizing antibody responses to pre‐ and post‐SARS‐CoV‐2 Omicron variants in participants infected early in the COVID‐19 pandemic, before widespread rollout of SARS‐CoV‐2 vaccines. Cross‐sectional regression models adjusted for clinical covariates and longitudinal mixed‐effects models were used to determine the impact of the breadth and rate of decay of neutralizing responses on the development of Long COVID symptoms, as well as Long COVID phenotypes. We identified several novel relationships between SARS‐CoV‐2 antibody neutralization and the presence of Long COVID symptoms. Specifically, we show that, although nAb responses to the original, infecting strain of SARS‐CoV‐2 were not associated with Long COVID in cross‐sectional analyses, cross‐neutralization ID 50 levels to the Omicron BA.5 variant approximately 4 months following acute infection was independently and significantly associated with greater odds of Long COVID and with persistent gastrointestinal and neurological symptoms. Longitudinal modeling demonstrated significant associations in the overall levels and rates of decay of neutralization capacity with Long COVID phenotypes. A higher proportion of participants had antibodies capable of neutralizing Omicron BA.5 compared with BA.1 or XBB.1.5 variants. Our findings suggest that relationships between various immune responses and Long COVID are likely complex but may involve the breadth of antibody neutralization responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
- Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, USA.
- Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
- Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
- Division of Pediatric Critical Care Medicine, University of California San Francisco, San Francisco, California, USA.
- Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, USA.
ORCID-Profile: Amanda M Buck
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Buck, A. M., Deitchman, A. N., Takahashi, S., Lu, S., Goldberg, S. A., Bodansky, A., Kung, A., Hoh, R., Williams, M. C., Kerbleski, M., Maison, D. P., Deveau, T. M., Munter, S. E., Lombardo, J., Wrin, T., Petropoulos, C. J., Durstenfeld, M. S., Hsue, P. Y., Kelly, J. D., …, & Henrich, T. J. (2023). The breadth of the neutralizing antibody response to original SARS‐CoV‐2 infection is linked to the presence of Long COVID symptoms. Journal of Medical Virology. https://doi.org/10.1002/jmv.29216
Vancouver
Buck AM, Deitchman AN, Takahashi S, Lu S, Goldberg SA, Bodansky A, et al. The breadth of the neutralizing antibody response to original SARS‐CoV‐2 infection is linked to the presence of Long COVID symptoms. Journal of Medical Virology. 2023. doi:10.1002/jmv.29216
BibTeX
@article{Buck2023,
author = {Buck, Amanda M and Deitchman, Amelia N and Takahashi, Saki and Lu, Scott and Goldberg, Sarah A and Bodansky, Aaron and Kung, Andrew and Hoh, Rebecca and Williams, Meghann C and Kerbleski, Marian and Maison, David P and Deveau, Tyler-Marie and Munter, Sadie E and Lombardo, James and Wrin, Terri and Petropoulos, Christos J and Durstenfeld, Matthew S and Hsue, Priscilla Y and Kelly, J Daniel and Greenhouse, Bryan and Martin, Jeffrey N and Deeks, Steven G and Peluso, Michael J and Henrich, Timothy J},
title = {The breadth of the neutralizing antibody response to original SARS‐CoV‐2 infection is linked to the presence of Long COVID symptoms},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.29216}
}
EUVIMED